Literature DB >> 11080038

Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy.

D Marko1, G Pahlke, K H Merz, G Eisenbrand.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11080038     DOI： 10.1021/tx000090l

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN： 0893-228X            Impact factor:   3.739


× No keyword cloud information.
  13 in total

1.  Inhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468.

Authors:  R Saravani; F Karami-Tehrani; M Hashemi; M Aghaei; R Edalat
Journal:  Cell Prolif       Date:  2012-04-02       Impact factor: 6.831

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Authors:  Patricia Goldhoff; Nicole M Warrington; David D Limbrick; Andrew Hope; B Mark Woerner; Erin Jackson; Arie Perry; David Piwnica-Worms; Joshua B Rubin
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

4.  The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma brucei.

Authors:  Roya Zoraghi; Thomas Seebeck
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

5.  Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.

Authors:  De-Chen Lin; Liang Xu; Ling-Wen Ding; Arjun Sharma; Li-Zhen Liu; Henry Yang; Patrick Tan; Jay Vadgama; Beth Y Karlan; Jenny Lester; Nicole Urban; Michèl Schummer; Ngan Doan; Jonathan W Said; Hongmao Sun; Martin Walsh; Craig J Thomas; Paresma Patel; Dong Yin; Daniel Chan; H Phillip Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

6.  Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule.

Authors:  Tae-Wook Kang; Soon Won Choi; Se-Ran Yang; Tae-Hoon Shin; Hyung-Sik Kim; Kyung-Rok Yu; In-Sun Hong; Seonggu Ro; Joong Myung Cho; Kyung-Sun Kang
Journal:  Sci Rep       Date:  2014-07-03       Impact factor: 4.379

7.  DHA induces apoptosis of human malignant breast cancer tissues by the TLR-4/PPAR-α pathways.

Authors:  Lijing Geng; Wei Zhou; Bing Liu; Xinyun Wang; Bo Chen
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

8.  Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition.

Authors:  Liping Sun; Haitian Quan; Chengying Xie; Lei Wang; Youhong Hu; Liguang Lou
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

9.  The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment.

Authors:  Alexandra M Fajardo; Gary A Piazza; Heather N Tinsley
Journal:  Cancers (Basel)       Date:  2014-02-26       Impact factor: 6.639

10.  Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.

Authors:  N Li; K Lee; Y Xi; B Zhu; B D Gary; V Ramírez-Alcántara; E Gurpinar; J C Canzoneri; A Fajardo; S Sigler; J T Piazza; X Chen; J Andrews; M Thomas; W Lu; Y Li; D J Laan; M P Moyer; S Russo; B T Eberhardt; L Yet; A B Keeton; W E Grizzle; G A Piazza
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.